Long term follow-up of patients with newly diagnosed glioblastoma treated by intraoperative photodynamic therapy: an update from the INDYGO trial (NCT03048240)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Long term follow-up of patients with newly diagnosed glioblastoma treated by intraoperative photodynamic therapy: an update from the INDYGO trial (NCT03048240) ; volume:168 ; number:3 ; day:16 ; month:5 ; year:2024 ; pages:495-505 ; date:7.2024
Journal of neuro-oncology ; 168, Heft 3 (16.5.2024), 495-505, 7.2024
- Urheber
-
Peciu-Florianu, Iulia
Vannod-Michel, Quentin
Vauleon, Enora
Bonneterre, Marie-Edith
Reyns, Nicolas
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11060-024-04693-4
- URN
-
urn:nbn:de:101:1-2409102120218.557387697114
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Peciu-Florianu, Iulia
- Vannod-Michel, Quentin
- Vauleon, Enora
- Bonneterre, Marie-Edith
- Reyns, Nicolas
- SpringerLink (Online service)
Ähnliche Objekte (12)
Interstitial photodynamic therapy for newly diagnosed glioblastoma
Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma
Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis
A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma
The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma
Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma
Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model
Feasibility of fractionated gamma knife radiosurgery in the management of newly diagnosed Glioblastoma
Early Therapeutic Interventions for Newly Diagnosed Glioblastoma: Rationale and Review of the Literature
Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma
Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma
Assessment of MGMT methylation status using high-performance liquid chromatography in newly diagnosed glioblastoma
Interstitial photodynamic therapy for newly diagnosed glioblastoma
Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma
Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis
A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma
The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma
Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma
Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model
Feasibility of fractionated gamma knife radiosurgery in the management of newly diagnosed Glioblastoma
Early Therapeutic Interventions for Newly Diagnosed Glioblastoma: Rationale and Review of the Literature
Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma
Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma
Assessment of MGMT methylation status using high-performance liquid chromatography in newly diagnosed glioblastoma
Interstitial photodynamic therapy for newly diagnosed glioblastoma
Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma
Newly Diagnosed IDH-Wildtype Glioblastoma and Temporal Muscle Thickness: A Multicenter Analysis
A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma
The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma
Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma
Personalized prognosis stratification of newly diagnosed glioblastoma applying a statistical decision tree model
Feasibility of fractionated gamma knife radiosurgery in the management of newly diagnosed Glioblastoma
Early Therapeutic Interventions for Newly Diagnosed Glioblastoma: Rationale and Review of the Literature
Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma
Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma